107 related articles for article (PubMed ID: 8930764)
1. Determination of the novel topoisomerase I inhibitor NU/ICRF 505 and its major metabolite in plasma, tissue and tumour by high-performance liquid chromatography.
Cummings J; Meikle I; Macpherson JS; Smyth JF
J Chromatogr B Biomed Appl; 1996 Oct; 685(1):159-64. PubMed ID: 8930764
[TBL] [Abstract][Full Text] [Related]
2. Characterization of the major metabolite of the novel topoisomerase I inhibitor NU/ICRF 505.
Cummings J; Meikle I; Macpherson JS; Smyth JF
Anticancer Drug Des; 1996 Jul; 11(5):367-82. PubMed ID: 8765530
[TBL] [Abstract][Full Text] [Related]
3. Accumulation of anthracenyl-amino acid topoisomerase I and II inhibitors in drug-sensitive and drug-resistant human ovarian cancer cell lines determined by high-performance liquid chromatography.
Cummings J; Meikle I; Macpherson JS; Smyth JF
Cancer Chemother Pharmacol; 1995; 37(1-2):103-9. PubMed ID: 7497578
[TBL] [Abstract][Full Text] [Related]
4. Enhanced clearance of topoisomerase I inhibitors from human colon cancer cells by glucuronidation.
Cummings J; Boyd G; Ethell BT; Macpherson JS; Burchell B; Smyth JF; Jodrell DI
Biochem Pharmacol; 2002 Feb; 63(4):607-13. PubMed ID: 11992628
[TBL] [Abstract][Full Text] [Related]
5. Induction of apoptosis in human cancer cell lines by the novel anthracenyl-amino acid topoisomerase I inhibitor NU/ICRF 505.
Meikle I; Cummings J; Macpherson JS; Smyth JF
Br J Cancer; 1996 Aug; 74(3):374-9. PubMed ID: 8695351
[TBL] [Abstract][Full Text] [Related]
6. Biochemistry of topoisomerase I and II inhibition by anthracenyl-amino acid conjugates.
Meikle I; Cummings J; Macpherson JS; Hadfield JA; Smyth JF
Biochem Pharmacol; 1995 Jun; 49(12):1747-57. PubMed ID: 7598737
[TBL] [Abstract][Full Text] [Related]
7. High-performance liquid chromatographic assay for the experimental anticancer agent oxantrazole.
Frank SK; Mathiesen DA; Whitfield LR; Ames MM
J Chromatogr; 1987 Aug; 419():225-32. PubMed ID: 3667780
[TBL] [Abstract][Full Text] [Related]
8. High-performance liquid chromatographic analysis of the anticancer drug oxantrazole in rat whole blood and tissues.
Hassan EE; Gallo JM
J Chromatogr; 1992 Nov; 582(1-2):225-31. PubMed ID: 1491045
[TBL] [Abstract][Full Text] [Related]
9. A high-performance liquid chromatographic assay for determination of cisplatin in plasma, cancer cell, and tumor samples.
Lopez-Flores A; Jurado R; Garcia-Lopez P
J Pharmacol Toxicol Methods; 2005; 52(3):366-72. PubMed ID: 16112590
[TBL] [Abstract][Full Text] [Related]
10. Glucuronidation as a mechanism of intrinsic drug resistance in colon cancer cells: contribution of drug transport proteins.
Cummings J; Zelcer N; Allen JD; Yao D; Boyd G; Maliepaard M; Friedberg TH; Smyth JF; Jodrell DI
Biochem Pharmacol; 2004 Jan; 67(1):31-9. PubMed ID: 14667926
[TBL] [Abstract][Full Text] [Related]
11. Determination of a new naphthoquinone derivative, NQ12, in human plasma and urine by high-performance liquid chromatography.
Kim SH; Park JM; Ryu CK; Lee MG
Res Commun Mol Pathol Pharmacol; 1999 Jan; 103(1):101-7. PubMed ID: 10440575
[TBL] [Abstract][Full Text] [Related]
12. Cytogenetic evaluation of the mechanism of cell death induced by the novel anthracenyl-amino acid topoisomerase II catalytic inhibitor NU/ICRF 500.
Cummings J; Sumner AT; Slavotinek A; Meikle I; Macpherson JS; Smyth JF
Mutat Res; 1995 Aug; 344(1-2):55-62. PubMed ID: 7565893
[TBL] [Abstract][Full Text] [Related]
13. Sensitive isocratic liquid chromatographic assay for the determination of 5,10,15,20-tetra(m-hydroxyphenyl)chlorin in plasma and tissue with electrochemical detection.
Barberi-Heyob M; Rezzoug H; Merlin JL; Guillemin F
J Chromatogr B Biomed Sci Appl; 1997 Jan; 688(2):331-8. PubMed ID: 9061472
[TBL] [Abstract][Full Text] [Related]
14. Ion-paired high-performance liquid chromatographic determination of mitoxantrone in physiological fluids.
van Belle SJ; Schoemaker TJ; Verwey SL; Paalman AC; McVie JG
J Chromatogr; 1985 Jan; 337(1):73-80. PubMed ID: 3980659
[TBL] [Abstract][Full Text] [Related]
15. Development of a high-performance liquid chromatographic method to determine the concentration of karenitecin, a novel highly lipophilic camptothecin derivative, in human plasma and urine.
Smith JA; Hausheer F; Newman RA; Madden TL
J Chromatogr B Biomed Sci Appl; 2001 Aug; 759(1):117-24. PubMed ID: 11499615
[TBL] [Abstract][Full Text] [Related]
16. Determination of desoxyepothilone B in nude mice plasma by liquid-liquid extraction and reversed-phase high-performance liquid chromatography.
Wang Z; Wang H; Rhie JK; Covey JM; Liang P; Wang S; Wang C; Hu Y; Prasad G; Nan L; Hill DL; Zhang R
J Pharm Biomed Anal; 2006 Sep; 42(2):272-6. PubMed ID: 16616824
[TBL] [Abstract][Full Text] [Related]
17. Cell cycle effects of the novel topoisomerase I inhibitor NU/ICRF 505 in a panel of Chinese hamster ovary cell lines.
Macpherson JS; Cummings J; Meikle I; Miller EP; Smyth JF
Eur J Cancer; 1997 Feb; 33(2):280-3. PubMed ID: 9135500
[TBL] [Abstract][Full Text] [Related]
18. High-performance liquid chromatographic analysis of AQ4N, an alkylaminoanthraquinone N-oxide.
Swaine DJ; Loadman PM; Bibby MC; Graham MA; Patterson LH
J Chromatogr B Biomed Sci Appl; 2000 Jun; 742(2):239-45. PubMed ID: 10901128
[TBL] [Abstract][Full Text] [Related]
19. Glucuronidation of SN-38 and NU/ICRF 505 in human colon cancer and adjacent normal colon.
Cummings J; Ethell BT; Jardine L; Burchell B
Anticancer Res; 2006; 26(3B):2189-96. PubMed ID: 16821585
[TBL] [Abstract][Full Text] [Related]
20. Detection and separation of the anthrapyrazole CI-941 and its metabolites in serum and urine by high-performance liquid chromatography.
Proksch B; Blanz J; Zeller KP; Ehninger G
J Chromatogr B Biomed Appl; 1994 Aug; 658(2):349-53. PubMed ID: 7820263
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
